Inventor · disambiguated record
Henrik Orum
Also filed as: ORUM HENRIK
14 granted patents·25 pending applications·479 citations·filing 1996–2021
94Inventor score
Files withROCHE INNOVATION CT COPENHAGEN AS16SANTARIS PHARMA AS6SAZANI PETER L4PNA DIAGNOSTICS AS3ORUM HENRIK2
Top patents by PatentIndex Score
39 records- 0196US9738894B2Short interfering RNA (siRNA) analoguesROCHE INNOVATION CT COPENHAGEN AS·Filed 2016·Granted Aug 22, 2017·55 cites·27 claims
- 0294US7622453B2Oligomeric compounds for the modulation of Bcl-2SANTARIS PHARMA AS·Filed 2004·Granted Nov 24, 2009·114 cites·57 claims
- 0393US8580756B2Short oligomer antagonist compounds for the modulation of target mRNAHANSEN JENS BO RODE·Filed 2008·Granted Nov 12, 2013·52 cites·17 claims
- 0487US10077443B2Oligonucleotide conjugatesROCHE INNOVATION CT COPENHAGEN AS·Filed 2013·Granted Sep 18, 2018·10 cites·22 claims
- 0586US6225052B1Method for determining a nucleic acidROCHE DIAGNOSTICS GMBH·Filed 1997·Granted May 1, 2001·101 cites·19 claims
- 0685US5843663AMethods of capturing nucleic acid analogs and nucleic acids on a solid supportPNA DIAGNOSTICS AS·Filed 1996·Granted Dec 1, 1998·59 cites·39 claims
- 0784US7105318B2Specific and sensitive nucleic acid detection methodROCHE DIAGNOSTICS GMBH·Filed 2002·Granted Sep 12, 2006·14 cites·7 claims
- 0876US2020283776A1Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of DiseaseROCHE INNOVATION CT COPENHAGEN AS·Filed 2019·Application pending·0 cites
- 0975US9297010B2Short interfering RNA (siRNA) analoguesSANTARIS PHARMA AS·Filed 2014·Granted Mar 29, 2016·2 cites·30 claims
- 1073US9566293B2Oral delivery of therapeutically effective LNA oligonucleotidesROCHE INNOVATION CT COPENHAGEN AS·Filed 2015·Granted Feb 14, 2017·3 cites·9 claims
- 1173US6117973APNA monomers with electron donor or acceptorGEORGIA TECH RES INST·Filed 1997·Granted Sep 12, 2000·45 cites·9 claims
- 1273US2021363222A1Soluble TNF Receptors and Their Use in Treatment of DiseaseROCHE INNOVATION CT COPENHAGEN AS·Filed 2020·Application pending·0 cites
- 1373US2019309047A1Soluble TNF Receptors and Their Use in Treatment of DiseaseROCHE INNOVATION CT COPENHAGEN AS·Filed 2019·Application pending·0 cites
- 1468US2021238601A1Oligonucleotide ConjugatesROCHE INNOVATION CT COPENHAGEN AS·Filed 2021·Application pending·0 cites
- 1568US2017198024A1Soluble TNF Receptors and Their Use in Treatment of DiseaseROCHE INNOVATION CT COPENHAGEN AS·Filed 2017·Application pending·0 cites
- 1666US11155816B2Oligonucleotide conjugatesROCHE INNOVATION CT COPENHAGEN AS·Filed 2018·Granted Oct 26, 2021·0 cites·24 claims
- 1766US2019017052A1Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of DiseaseROCHE INNOVATION CT COPENHAGEN AS·Filed 2018·Application pending·0 cites
- 1865US9364495B2Oral delivery of therapeutically effective LNA oligonucleotidesHARDEE GREGROY·Filed 2010·Granted Jun 14, 2016·2 cites·17 claims
- 1964US2018051290A1Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of DiseaseROCHE INNOVATION CT COPENHAGEN AS·Filed 2017·Application pending·0 cites
- 2064US2013123479A1Soluble TNF Receptors and Their Use in Treatment of DiseaseSAZANI PETER L·Filed 2012·Application pending·0 cites
- 2163US2009325301A1Modulation of the binding properties of nucleic acid binding partnersORUM HENRIK·Filed 2009·Application pending·0 cites
- 2262US2014057968A1Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of DiseaseSAZANI PETER L·Filed 2013·Application pending·0 cites
- 2362US2009264353A1Splice Switching Oligomers for TNF Superfamily Receptors and their Use in Treatment of DiseaseSANTARIS PHARMA AS·Filed 2007·Application pending·0 cites
- 2462US2017191067A1Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of DiseaseROCHE INNOVATION CT COPENHAGEN AS·Filed 2017·Application pending·0 cites
- 2562US2007105807A1Splice switch oligomers for TNF superfamily receptors and their use in treatment of diseaseSAZANI PETER L·Filed 2006·Application pending·0 cites
- 2661US2015166634A1Soluble TNF Receptors and Their Use in Treatment of DiseaseROCHE INNOVATION CT COPENHAGEN AS·Filed 2015·Application pending·0 cites
- 2759US2014357849A1Splice switching oligomers for tnf superfamily receptors and their use in treatment of diseaseSANTARIS PHARMA AS·Filed 2013·Application pending·0 cites
- 2856US2011237521A1Splice switching oligomers for tnf superfamily receptors and their use in treatment of diseaseSAZANI PETER L·Filed 2010·Application pending·0 cites
- 2952US5861250AProtecting nucleic acids and methods of analysisPNA DIAGNOSTICS AS·Filed 1996·Granted Jan 19, 1999·19 cites·23 claims
- 3051US2017015697A1Splice switching oligomers for tnf superfamily receptors and their use in treatment of diseaseROCHE INNOVATION CT COPENHAGEN AS·Filed 2015·Application pending·0 cites
- 3150US2016289677A1APOB Antisense Conjugate CompoundsROCHE INNOVATION CT COPENHAGEN AS·Filed 2014·Application pending·0 cites
- 3249US2019359986A1Splice switching oligomers for tnf superfamily receptors and their use in treatment of diseaseROCHE INNOVATION CT COPENHAGEN AS·Filed 2019·Application pending·0 cites
- 3344US2009176977A1Lna modified phosphorothiolated oligonucleotidesELMEN JOACIM·Filed 2007·Application pending·0 cites
- 3443US2003125241A1Therapeutic uses of LNA-modified oligonucleotides in infectious diseasesFiled 2002·Application pending·0 cites
- 3542US2008249039A1Modified Short Interfering Rna (Modified Sirna)SANTARIS PHARMA AS·Filed 2005·Application pending·0 cites
- 3641US2006101877A1Safety box for storing personal valuables, a safety anchor for securing the safety box and safety fasteners for securing a variety of other objectsORUM HENRIK·Filed 2003·Application pending·0 cites
- 3740US6346378B2Nucleic acid analogs with a chelating functionalityPNA DIAGNOSTICS AS·Filed 1998·Granted Feb 12, 2002·3 cites·6 claims
- 3838US2015252371A1Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of DiseaseSANTARIS PHARMA AS·Filed 2015·Application pending·0 cites
- 3936US2002068709A1Therapeutic uses of LNA-modified oligonucleotidesFiled 2000·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Henrik Orum files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →